Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Towa Pharmaceutical Co. Ltd.

www.towayakuhin.co.jp/english/

Latest From Towa Pharmaceutical Co. Ltd.

Towa Expects To Grow By Over A Third With Pensa

Towa says it expects consolidating the Pensa business it acquired earlier this year to boost its sales by more than a third in its current financial year. Meanwhile, the Japanese firm has reported sales ahead by 5% in the year ended March 2020 on the back of new launches, as well as growth in profits despite local price cuts.

Sales & Earnings Deals

Asia Deal Watch: Strides Obtains 18 US ANDAs From Pharmaceutics

Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…

Deals Business Strategies

Towa Hits Profit Target Three Months Early

Japan’s Towa has almost achieved its full-year operating profit goal in the first nine months of its financial year thanks to lower costs.

Sales & Earnings Strategy

Towa Completes Deal For Pensa

Japan’s Towa has completed its €329m deal for the Pensa Investments generics business of Spain’s Esteve.

Deals Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Towa Pharmaceutical Co. Ltd.
  • Senior Management
  • Itsuro Yoshida, Pres. & CEO
    Shinya Kida, Gen. Mgr., Fin. & Accounting
  • Contact Info
  • Towa Pharmaceutical Co. Ltd.
    Phone: (81) 6 69009103
    2-11 Shinbashi-Cho
    Kadoma
    Osaka, 571-8580
    Japan
UsernamePublicRestriction

Register